Risha Gidwani

Photo of Risha Gidwani
Senior Policy Researcher
Santa Monica Office


Dr.P.H. in health services, UCLA


Risha Gidwani is a senior policy researcher at the RAND Corporation. Also an adjunct associate professor at the UCLA School of Public Health, she uses both econometric and decision analysis methods to evaluate the value of healthcare.

Gidwani's work focuses on benefit design, cost-effectiveness, patient financial burden, and health policy.  She has studied quality of care, health system costs, patient out-of-pocket costs, patient-reported outcomes, utilities, disparities, value-based purchasing, and the comparative effectiveness and cost-effectiveness of interventions. Much of her work has compared health system performance across Medicare and VA, often focusing on cancer and end-of-life care. 

Gidwani has been principal investigator on multiple peer-reviewed studies evaluating the cost and quality of U.S. healthcare.  Her research has been published in peer-reviewed journals such as Health Affairs, JAMA Network Open, and Medical Care, among others. 

Prior to coming to RAND, she was a health economist at the VA Health Economics Resource Center (HERC), a core investigator at the VA Center for Innovation to Implementation (Ci2i), and a consulting assistant professor at the Stanford University School of Medicine. Gidwani received her Doctor of Public Health (Dr.P.H.) degree from the UCLA Department of Health Services.

Concurrent Non-RAND Positions

Adjunct Associate Professor, UCLA School of Public Health

Selected Publications

Gidwani-Marszowski R, Asch SM, Mor V, Wagner T, Faricy-Anderson K, Illarmo SM, Hsin G, Patel M, Ramchandran K, Lorenz M, Needleman J., "Health System and Beneficiary Costs Associated with Intensive End-of-Life Medical Services.," JAMA Network Open, 2019

Gidwani-Marszowski R, Needleman J, Mor V, Wagner T, Faricy-Anderson K, Boothroyd D, Patel M, Ramchandran K, Murrell SM, Joyce V and Asch SM., "The Quality of End-of-Life Care is Higher in VA than in Medicare: An Evaluation of a Dually-Eligible Population," Health Affairs, 37(1), 2018

Gidwani R and Bhattacharya J., "CMS Payment Reform and the Incidence of Hospital-Acquired Pulmonary Embolism or Deep Vein Thrombosis," Journal of General Internal Medicine, 30(5), 2015

Gidwani-Marszowski R, Kinosian B, Scott W, Phibbs C, Intrator O., "Hospice Care in Medicare Advantage versus Traditional Medicare Among Veterans: a Risk-Adjusted Analysis.," Journal of the American Geriatrics Society, (8), 2018

Gidwani-Marszowski R, Boothroyd D, Needleman J, Illarmo S, Asch SM., "Comorbidity Assessment is Uneven across VA and Medicare for the Same Patient: Implications for Risk-Adjustment.," Medical Care, 2020 (forthcoming)

Gidwani-Marszowski R, Nevedal A, Blayney DB, Patel M, Kelly PA, Timko C, Ramchandran K, Asch SM., "The Appropriate Role of Value in Treating Patients with Advanced Cancer: Oncologists’ Perspectives," Value in Health, 21(8), 2018

Gidwani R, Sinnott P, Avoundjian T, Lo J, Asch SM, Barnett PG., "Inappropriate ordering of lumbar spine magnetic resonance imaging: are providers Choosing Wisely?" American Journal of Managed Care, 22(2), 2016

Gidwani R, Khan ZM, Fenaux P, Beach CL & Pashos CL., "A cost-effectiveness analysis of using azacitidine vs. decitabine in treating patients with myelodysplastic syndromes.," Journal of Medical Economics. 2012, 15(1), 2012